Copyright
©The Author(s) 2020.
World J Clin Cases. Aug 26, 2020; 8(16): 3493-3502
Published online Aug 26, 2020. doi: 10.12998/wjcc.v8.i16.3493
Published online Aug 26, 2020. doi: 10.12998/wjcc.v8.i16.3493
Table 2 Comparison of baseline data between hepatocellular carcinoma group and healthy group
| Group | Number of cases | Age | BMI |
| Cancer group | 162 | 51.31 ± 4.21 | 26.04 ± 2.54 |
| Health group | 162 | 52.30 ± 5.28 | 25.73 ± 2.55 |
| t | 1.87 | 0.31 | |
| P value | 0.06 | 0.27 | |
- Citation: Guo Z, Wang J, Li L, Liu R, Fang J, Tie B. Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization. World J Clin Cases 2020; 8(16): 3493-3502
- URL: https://www.wjgnet.com/2307-8960/full/v8/i16/3493.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i16.3493